Intravitreal Bevacizumab for Macular Edema Due to Central Retinal Vein Occlusion: Perfused vs. Ischemic and Early vs. Late Treatment

By DeCroos Francis Char   Ehlers Justis P.   Stinnett Sandra   Fekrat Sharon  

Current Eye Research, Vol. 36, Iss. 12, 2011-12 ,pp. : 1164-1170

Informa Healthcare

Access to resources Recommend Favorite

A Comparison of Three Different Intravitreal Treatment Modalities of Macular Edema Due to Branch Retinal Vein Occlusion

By Çekiç Osman   Çakır Mehmet   Yazıcı Ahmet Taylan   Alagöz Neşe   Bozkurt Ercüment   Faruk Yılmaz Ömer  

Current Eye Research, Vol. 35, Iss. 10, 2010-10 ,pp. : 925-929

Informa Healthcare

Access to resources Recommend Favorite

Intravitreous Bevacizumab Treatment for Macular Edema due to Central Retinal Vein Occlusion

By Axer-Siegel Ruth   Dotan Assaf   Mimouni Karin   Bor Elite   Weinberger Dov   Bourla Dan Haim  

Current Eye Research, Vol. 37, Iss. 9, 2012-09 ,pp. : 818-822

Informa Healthcare

Access to resources Recommend Favorite

Intravitreal Bevacizumab and Cytokine Levels in Major and Macular Branch Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 225, Iss. 3, 2010-12 ,pp. : 150-154

Karger

Access to resources Recommend Favorite

Intravitreal Triamcinolone for Cystoid Macular Edema Related to Branch Retinal Vein Occlusion

By  

Annals of Ophthalmology, Vol. 38, Iss. 4, 2006-12 ,pp. : 317-320

Humana Press, Inc

Access to resources Recommend Favorite